PAL Technologies Ltd

PAL Technologies Ltd is a spin out from the University of Strathclyde’s Bioengineering Unit. Founded in 2001, the company’s innovative clinical research tools have gained world-wide recognition for their ability to accurately and objectively quantify physical behaviours across a wide range of clinical populations.

PAL Technologies

An award winning company, PAL Technologies provides clinical tools for patient-centred measurement of free-living, everyday physical activities and behaviour, providing researchers and clinicians with robust evidence for treatment interventions and disease related risks. 

Based on more than 25 years of R&D across a range of patient groups, PAL’s miniaturised single sensor platform technology also optimises more recent developments in advanced Micro-Electro-Mechanical Systems (MEMS).

The activPAL™ is the world’s first single-site instrument that is validated to quantify posture allocation. It is the researcher’s preferred choice for quantifying not only free-living upright and ambulatory activities, but also sedentary activities which are increasingly being recognised as having a significant role in mortality associated with cardiometabolic diseases. The small, lightweight instrument (think of a matchbox but slimmer) is worn on the subject’s thigh like a sticking plaster and can be worn constantly for up to a week at a time. This allows the type (eg sitting, lying, standing, stepping) and intensity of a subject’s activities to be measured in intervals from seconds up to weeks and the information is fed back to researchers via custom designed software. The resulting data may then be downloaded in clear, easily understood graphs or into spreadsheets for further analysis.

Since 2001 PAL Technologies has been providing support from its headquarters in Glasgow to in excess of 200 customers worldwide, based in research centres across 50 countries, who are investigating the correlation between levels and types of physical activity and chronic disease. By working in close partnership with its customers to deliver clinically relevant measures to support and inform patient-centred treatment approaches, PAL Technologies is proud to be helping to build healthier lives.

PAL Technologies also supplies the Long-term Ambulatory Monitor (LAM) for amputees providing an objective measure of prosthetic limb use over periods of up to 24 months.